Drug recalls

Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye Drops (glycerin 0.25%, naphazoline hydrochloride 0.012%) , 0.5 fl oz (15mL) per d…

Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company · Lack of Assurance of Sterility

Class IIOngoingD-0870-2026
Status
Ongoing
City
Tarrytown
State
NY
Country
United States
Classification
Class II
Product type
Drugs
Event ID
99909
Recalling firm
Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company
Address 1
660 White Plains Rd Ste 250
Postal code
10591-5171
Voluntary mandated
Voluntary: Firm initiated
Initial firm notification
Letter
Distribution pattern
Nationwide in the USA.
Recall number
D-0870-2026
Product quantity
2,356,248 bottles
Reason for recall
Lack of Assurance of Sterility
Recall initiation date
20260915
Center classification date
20260923
Report date
20260930
Product description

Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye Drops (glycerin 0.25%, naphazoline hydrochloride 0.012%) , 0.5 fl oz (15mL) per dropper bottle, STERILE, Dist. by Medtech Products Inc., Tarrytown, NY 10591. NDC: 67172-797-15

Code info

Lot #: RL25G02, RL25G03, RL25G04, Exp. Date Jul-27; RL25H02, RL25H03, RL25H04, Exp. Date Aug-27; RL25K01, RL25K02, RL25K03, RL25K04, Exp. Date Sep-27; RL25M01, RL25M02, RL25M03, RL25M04, Exp. Date Oct-27; RL25N01, RL25N02, RL25N04, Exp. Date Nov-27.

Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.